CVNA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CVNA is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 who is unwilling to wait for a better entry. The stock has already run to 399-400 and sits near resistance while momentum is mixed, so the current setup is stretched rather than attractive for a fresh long-term buy. I would not buy it here; I would hold off for a pullback or a clearer breakout confirmation.
The trend is constructive but no longer cheap. Price is around 399-400, above the pivot at 393.774 and close to resistance at 413.655, with R2 at 425.937. RSI_6 at 63.059 is neutral-to-strong but not oversold, suggesting limited immediate upside from this level. MACD histogram is -2.641 and still below zero, though contracting, which means bearish momentum is easing but not fully reversed. Moving averages are converging, signaling a potentially late-stage consolidation rather than a clean low-risk entry. The one-day trend expectation is modestly positive, but the next week and month estimates are negative, which argues against chasing the stock here.
["Q1 revenue rose 51.98% YoY to 6.432B, showing strong growth momentum.", "Net income and EPS both improved year over year, indicating profitability is still expanding.", "Analysts broadly raised price targets after Q1 results, with multiple Buy/Overweight ratings and targets in the 465-600 range.", "Hedge funds are buying, with buying amount up 114.01% over the last quarter.", "Congress trading data shows 1 purchase and no sales in the last 90 days, a mildly positive signal.", "Company is expanding its Chicago inspection and reconditioning center, supporting operational growth."]
["Gross margin fell to 19.76, down 9.98% YoY, indicating margin pressure despite revenue growth.", "Stock has already surged massively since 2022, making the current entry look extended.", "MACD remains below zero, so trend momentum is not fully confirmed.", "News about a 5-for-1 forward split is more accessibility-focused than a fundamental growth catalyst.", "A reported sale from BHJ C Trust adds a small supply overhang.", "Near-term stock trend estimate points to weakness over the next week and month."]
In Q1 2026, Carvana posted strong top-line growth with revenue up 51.98% YoY to 6.432B. Net income increased 15.74% YoY to 250M and EPS rose 11.92% YoY to 1.69, which confirms continued earnings improvement. The main weakness was gross margin, which dropped to 19.76, down 9.98% YoY, suggesting profitability expansion is still vulnerable to cost or mix pressure. Overall, the latest quarter was strong on growth and solid on earnings, but margin compression remains the key issue.
Analyst sentiment is clearly positive overall. Since Q1, several firms raised price targets: Citizens to 515 with Outperform, Deutsche Bank to 537 with Buy, Needham to 600 with Buy, BTIG to 485 with Buy, Morgan Stanley to 510 with Overweight, Wells Fargo to 475 with Overweight, UBS to 520 with Buy, and JPMorgan to 465 with Overweight. Evercore is still In Line and Baird remains Neutral, so there is still some caution, but the dominant Wall Street view is bullish. The pros see durable efficiency gains, strong unit growth, and further margin improvement; the main con is that some analysts believe the stock has already re-rated significantly and near-term upside may be less attractive at current levels.
